![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
taxidermy (chapter 1)
Nov. 12th, 2026 01:51 amTags: omegaverse
TW: medical misogyny
_ _ _
Chinese Journal of Sex Medicine
Volume 23 Issue 7
Yang Ruichen & Chen Xia
Anaphylactic reaction to fomicene citrate: Case report
Anaphylaxis is an acute multisystem syndrome caused by systematic degranulation of mast cells or basophils. Mortality is low, less than 2%, due to the advent of portable self-administered epinephrine devices. While many drugs, particularly antibiotics, are commonly reported by patients to induce allergic reactions, anaphylactic reactions to fomicene citrate are rare, with fewer than 50 cases identified since the drug came to market in 2000.
Over the past two decades, advances in beta fertility have stalled, and the majority of live births, especially second and third pregnancies, still occur in omegas. Patient who experience a subnormal number of annual heats experience poorer outcomes; they are less likely on average to become pregnant, and their alphas report higher rates of dissatisfaction with their marriages. Preservation of fertility in omegas is therefore paramount as a matter of public health. To this end, in 2007 the World Society of Sex Medicine released new guidelines for the management of delayed presentation in omegas. These have been widely adopted. Per these guidelines, ideally, all adolescent omegas should have induction of heat before age eighteen, in order to facilitate the maximum number of child-bearing years.
With the mass availability of new, safer heat induction agents, many more patients can safely undergo heat induction. However, complications can still occur.
We present the case of a 17-year-old omega male with a history of delayed presentation[1], who was brought to an outpatient infusion center for parenteral heat induction therapy with fomicene citrate after a failure to respond to oral therapy. Previously, the patient had been evaluated for causes of delayed presentation. His endocrinologist performed an extensive workup, including serum adrenocorticotropic hormone, thyroid stimulating hormone, free T4, as well as cyclotropin-releasing hormone, menegen and heliosterone levels[2]. In addition, computed tomography of the head, sella, and adrenals was obtained, along with sonography of the pelvis.
The patient was found to have isolated cyclotropin-releasing hormone deficiency, a rare cause of delayed presentation. Initially he was treated with 50 mcg twice daily of fomicene citrate by mouth. However, he failed to respond, and was subsequently titrated to the maximum dose at 300 mcg over five months. Serial cyclotropin-releasing hormone levels as well as cyclotropin levels were taken every four weeks, and the patient continued to have failure of induction.
He was therefore referred for parenteral therapy with outpatient infusions of fomicene citrate. During the infusion, he suffered an anaphylactic reaction and received prompt administration of intramuscular epinephrine. He failed to respond, and was transported emergently to the nearest emergency department by ambulance. After three doses of intramuscular epinephrine, which were ineffective, he was intubated in the emergency department. It was then discovered that patient had taken a dose of his prescribed propanolol prior to the infusion. After a dose of glucagon, patient was started on an epinephrine drip, and he was stabilized and transported to the ICU.
During his subsequent hospitalization, multiple heat induction therapies were trialed, including fomicene citrate with premedication as well as pronezole and acetylmenin. Patient was unable to tolerate any agent. Furthermore, he continued to have persistent failure of induction.
Finally, due to patient’s age, he was started on parenteral xamozine. While xamozine was previously a common agent for heat induction, the introduction of agents such as fomicene citrate, with their markedly reduced risk of thrombosis, have rendered them largely obsolete. In this case, patient was responsive to xamozine, and induction of heat was successfully achieved. Patient’s cyclotropin levels were appropriately elevated on repeat testing, and he was discharged home with oral therapy with xamozine.
1. Delayed presentation is defined as failure to have aletharche (spontaneous onset of heat or rut) by age sixteen.[top]
2. Cyclotropins (menegen and heliosterone) are the primary reproductive hormones in alpha and omegas. In betas, the gonadotropins (estrogen and testosterone) are predominant, which is thought to contribute to their relative infertility.[top]
TW: medical misogyny
_ _ _
Chinese Journal of Sex Medicine
Volume 23 Issue 7
Yang Ruichen & Chen Xia
Anaphylactic reaction to fomicene citrate: Case report
Anaphylaxis is an acute multisystem syndrome caused by systematic degranulation of mast cells or basophils. Mortality is low, less than 2%, due to the advent of portable self-administered epinephrine devices. While many drugs, particularly antibiotics, are commonly reported by patients to induce allergic reactions, anaphylactic reactions to fomicene citrate are rare, with fewer than 50 cases identified since the drug came to market in 2000.
Over the past two decades, advances in beta fertility have stalled, and the majority of live births, especially second and third pregnancies, still occur in omegas. Patient who experience a subnormal number of annual heats experience poorer outcomes; they are less likely on average to become pregnant, and their alphas report higher rates of dissatisfaction with their marriages. Preservation of fertility in omegas is therefore paramount as a matter of public health. To this end, in 2007 the World Society of Sex Medicine released new guidelines for the management of delayed presentation in omegas. These have been widely adopted. Per these guidelines, ideally, all adolescent omegas should have induction of heat before age eighteen, in order to facilitate the maximum number of child-bearing years.
With the mass availability of new, safer heat induction agents, many more patients can safely undergo heat induction. However, complications can still occur.
We present the case of a 17-year-old omega male with a history of delayed presentation[1], who was brought to an outpatient infusion center for parenteral heat induction therapy with fomicene citrate after a failure to respond to oral therapy. Previously, the patient had been evaluated for causes of delayed presentation. His endocrinologist performed an extensive workup, including serum adrenocorticotropic hormone, thyroid stimulating hormone, free T4, as well as cyclotropin-releasing hormone, menegen and heliosterone levels[2]. In addition, computed tomography of the head, sella, and adrenals was obtained, along with sonography of the pelvis.
The patient was found to have isolated cyclotropin-releasing hormone deficiency, a rare cause of delayed presentation. Initially he was treated with 50 mcg twice daily of fomicene citrate by mouth. However, he failed to respond, and was subsequently titrated to the maximum dose at 300 mcg over five months. Serial cyclotropin-releasing hormone levels as well as cyclotropin levels were taken every four weeks, and the patient continued to have failure of induction.
He was therefore referred for parenteral therapy with outpatient infusions of fomicene citrate. During the infusion, he suffered an anaphylactic reaction and received prompt administration of intramuscular epinephrine. He failed to respond, and was transported emergently to the nearest emergency department by ambulance. After three doses of intramuscular epinephrine, which were ineffective, he was intubated in the emergency department. It was then discovered that patient had taken a dose of his prescribed propanolol prior to the infusion. After a dose of glucagon, patient was started on an epinephrine drip, and he was stabilized and transported to the ICU.
During his subsequent hospitalization, multiple heat induction therapies were trialed, including fomicene citrate with premedication as well as pronezole and acetylmenin. Patient was unable to tolerate any agent. Furthermore, he continued to have persistent failure of induction.
Finally, due to patient’s age, he was started on parenteral xamozine. While xamozine was previously a common agent for heat induction, the introduction of agents such as fomicene citrate, with their markedly reduced risk of thrombosis, have rendered them largely obsolete. In this case, patient was responsive to xamozine, and induction of heat was successfully achieved. Patient’s cyclotropin levels were appropriately elevated on repeat testing, and he was discharged home with oral therapy with xamozine.
1. Delayed presentation is defined as failure to have aletharche (spontaneous onset of heat or rut) by age sixteen.[top]
2. Cyclotropins (menegen and heliosterone) are the primary reproductive hormones in alpha and omegas. In betas, the gonadotropins (estrogen and testosterone) are predominant, which is thought to contribute to their relative infertility.[top]
